Further, therapy with cytokines, such as IL-2 gene therapy in a metastatic breast cancer model, can induce anti-tumor immunity that represses the growth of primary tumors or subsequent challenges [90,91,92]. The gene discussed is IL2; the disease is breast carcinoma.